Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Veracyte, Inc.
4366
Veracyte, Inc.
Health Care
Technology
Biotechnology
Veracyte, a pioneer in molecular cytology, develops molecular diagnostic tests that enable doctors to choose to avoid unnecessary invasive procedures.
Suggest edits
Founded
2008
Raised
$116M
Follow us
Also headquartered in South San Francisco
Genentech
insitro
MyoKardia
Sutro Biopharma
Freenome
SuccessFactors
Plenty
Theravance
Cytokinetics, Inc.
Dispatch
Companies in the same industry
Innovative Cardiovascular Solutions
Rubius Therapeutics
Made of Genes
xMD Diagnostics
Allakos Inc
JW Therapeutics
Genetron Health
MHC Asia Group
Neurogenica
Altimmune
Alexa global traffic share
Twitter followers
Overview
Funding
4
Acquisitions
1
Add info
Latest funding
Show all
$45,000,000
Debt financing - 2016
$28,000,000
Venture capital (Series C) - 2013
Kleiner Perkins Caufield & Byers
TPG Biotech
GE Ventures
+2
Team Size
50+
Employees
I work here
Location
South San Francisco
,
United States
Headquarters
Explore South San Francisco
Xconomy
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
MedCity News
Veracyte partners with J&J on development of lung cancer test
